Page last updated: 2024-08-25

methyl syringate and Cancer of Lung

methyl syringate has been researched along with Cancer of Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jin, M; Lee, Y; Park, J; Rhyu, MR; Shim, MK	1

Other Studies

1 other study(ies) available for methyl syringate and Cancer of Lung

Article	Year
Methyl syringate, a TRPA1 agonist represses hypoxia-induced cyclooxygenase-2 in lung cancer cells. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2016, Mar-15, Volume: 23, Issue:3 Topics: Calcium Channels; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Epithelial Cells; Gallic Acid; Humans; Lung Neoplasms; Neoplasm Invasiveness; Nerve Tissue Proteins; Promoter Regions, Genetic; Transient Receptor Potential Channels; TRPA1 Cation Channel; Vascular Endothelial Growth Factor A	2016

Article

Year

Methyl syringate, a TRPA1 agonist represses hypoxia-induced cyclooxygenase-2 in lung cancer cells.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2016, Mar-15, Volume: 23, Issue:3

Topics: Calcium Channels; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Epithelial Cells; Gallic Acid; Humans; Lung Neoplasms; Neoplasm Invasiveness; Nerve Tissue Proteins; Promoter Regions, Genetic; Transient Receptor Potential Channels; TRPA1 Cation Channel; Vascular Endothelial Growth Factor A

2016